LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 125 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $56,000 | -57.9% | 10,000 | -50.0% | 0.00% | -100.0% |
Q4 2018 | $133,000 | -37.6% | 20,000 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $213,000 | -6.6% | 20,000 | +5.3% | 0.00% | 0.0% |
Q2 2018 | $228,000 | +51.0% | 19,000 | +8.0% | 0.00% | 0.0% |
Q1 2018 | $151,000 | -13.2% | 17,600 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $174,000 | -19.4% | 17,600 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $216,000 | -25.5% | 17,600 | 0.0% | 0.00% | -50.0% |
Q2 2017 | $290,000 | +15.1% | 17,600 | 0.0% | 0.00% | +100.0% |
Q1 2017 | $252,000 | +3.7% | 17,600 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $243,000 | -23.6% | 17,600 | 0.0% | 0.00% | -50.0% |
Q3 2016 | $318,000 | +16.1% | 17,600 | -7.9% | 0.00% | 0.0% |
Q2 2016 | $274,000 | +20.2% | 19,100 | 0.0% | 0.00% | +100.0% |
Q1 2016 | $228,000 | -10.2% | 19,100 | 0.0% | 0.00% | -50.0% |
Q4 2015 | $254,000 | +66.0% | 19,100 | +33.7% | 0.00% | +100.0% |
Q3 2015 | $153,000 | +33.0% | 14,285 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $115,000 | – | 14,285 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Artal Group S.A. | 71,178,364 | $280,443,000 | 7.61% |
BVF INC/IL | 14,360,000 | $56,578,000 | 2.05% |
Integral Health Asset Management, LLC | 200,000 | $788,000 | 0.22% |
Eversept Partners, LP | 797,694 | $3,142,914 | 0.20% |
NEA Management Company, LLC | 2,382,286 | $9,386,000 | 0.19% |
PINNACLE ASSOCIATES LTD | 2,127,662 | $8,383,000 | 0.14% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $141,000 | 0.06% |
Virtus ETF Advisers LLC | 41,584 | $164,000 | 0.06% |
Pegasus Asset Management, Inc. | 10,000 | $39,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 31,562 | $124,000 | 0.02% |